全文获取类型
收费全文 | 9049篇 |
免费 | 455篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 176篇 |
儿科学 | 516篇 |
妇产科学 | 218篇 |
基础医学 | 895篇 |
口腔科学 | 493篇 |
临床医学 | 653篇 |
内科学 | 1791篇 |
皮肤病学 | 280篇 |
神经病学 | 618篇 |
特种医学 | 311篇 |
外科学 | 1611篇 |
综合类 | 78篇 |
一般理论 | 1篇 |
预防医学 | 660篇 |
眼科学 | 228篇 |
药学 | 525篇 |
中国医学 | 41篇 |
肿瘤学 | 427篇 |
出版年
2023年 | 87篇 |
2022年 | 127篇 |
2021年 | 225篇 |
2020年 | 165篇 |
2019年 | 195篇 |
2018年 | 246篇 |
2017年 | 197篇 |
2016年 | 236篇 |
2015年 | 274篇 |
2014年 | 340篇 |
2013年 | 450篇 |
2012年 | 518篇 |
2011年 | 542篇 |
2010年 | 314篇 |
2009年 | 260篇 |
2008年 | 397篇 |
2007年 | 442篇 |
2006年 | 480篇 |
2005年 | 477篇 |
2004年 | 468篇 |
2003年 | 422篇 |
2002年 | 396篇 |
2001年 | 341篇 |
2000年 | 292篇 |
1999年 | 254篇 |
1998年 | 90篇 |
1997年 | 65篇 |
1996年 | 65篇 |
1995年 | 53篇 |
1994年 | 35篇 |
1993年 | 37篇 |
1992年 | 91篇 |
1991年 | 62篇 |
1990年 | 69篇 |
1989年 | 66篇 |
1988年 | 42篇 |
1987年 | 48篇 |
1986年 | 47篇 |
1985年 | 40篇 |
1984年 | 35篇 |
1979年 | 34篇 |
1978年 | 28篇 |
1974年 | 31篇 |
1973年 | 36篇 |
1972年 | 28篇 |
1971年 | 33篇 |
1970年 | 30篇 |
1969年 | 31篇 |
1968年 | 30篇 |
1967年 | 30篇 |
排序方式: 共有9522条查询结果,搜索用时 62 毫秒
1.
2.
3.
Increased arterial stiffness in young normotensive patients with Turner syndrome: associations with vascular biomarkers
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
4.
5.
Luis Gajate Ascensión Martín Elena Elías Maria T Tenorio Angélica de Pablo Cristina Carrasco Adolfo Martínez Angel Candela Javier Zamora Fernando Lia?o 《Liver transplantation》2006,12(9):1371-1380
Although renal dysfunction is common after liver transplantation, postoperative renal function after split liver transplantation (SLT) has not been well studied. Renal function immediately after surgery was analyzed retrospectively in 16 patients that received a SLT (SLT group). The results were compared with corresponding data from 31 matched patients that received a full-size liver transplant (FSLT group) during the same period. Serum creatinine (SCr) was measured before surgery, and, after transplantation, daily during the first week and at days 14, 21, and 28. Renal dysfunction (RD) was defined as the requirement for renal replacement therapy (RRT) or a 100% increase in SCr if the basal value had been <1.0 mg/dL or a 50% increase in SCr if the basal value had been >1.0 mg/dL. SCr had to be at least 1.5 mg/dL for a diagnosis of RD to be considered. The classification of RD was: mild, SCr 1.5-2.4 mg/dL; moderate, SCr 2.5-4.0 mg/dL; or severe, SCr >4.0 mg/dL (the requirement for RRT). Both donor and recipient age and cold ischemia time were lower in the SLT group than in the FSLT group (P < 0.05). Length of surgery was longer in the SLT group (P < 0.05). There were no significant differences between groups with respect to Model for End-Stage Liver Disease scores, the need for transfusions, the length of admission to the intensive care unit (ICU), survival rate, individual severity index, or sepsis-related organ failure assessment scores at the time of diagnosing RD. Immunosuppression regimens were similar in both groups. RD developed in 82% of SLT patients, but in only 58% of FSLT patients (P = not significant [NS]). Among SLT patients, RD (23.0% mild, 15.5% moderate, and 61.5% severe) was more severe (P = 0.007) than in FSLT patients (63.1% mild, 15.8% moderate, and 24.1% severe). The requirement for RRT in the SLT group (43.7%) was significantly greater (P < 0.05) than that in the FSLT group (12.9%). This finding may be due to the different incidence of sepsis in the 2 groups (SLT 37.5% vs. FSLT 9.7%; P < 0.05). In conclusion, although the number of patients studied was small, our data suggest a higher incidence of RD and a greater requirement for RRT in patients that receive a split liver graft than in those that receive a full size liver graft. 相似文献
6.
7.
Compromise of immune function in obstructive jaundice. 总被引:5,自引:0,他引:5
8.
E Maquarre C Artus Z Gadhoum C Jasmin F Smadja-Joffe J Robert-Lézénès 《Leukemia》2005,19(12):2296-2303
We have recently reported that ligation of the CD44 cell surface antigen with A3D8 monoclonal antibody (mAb) triggers incomplete differentiation and apoptosis of the acute promyelocytic leukemia (APL)-derived NB4 cells. The present study characterizes the mechanisms underlying the apoptotic effect of A3D8 in NB4 cells. We show that A3D8 induces activation of both initiator caspase-8 and -9 and effector caspase-3 and -7 but only inhibition of caspase-3/7 and caspase-8 reduces A3D8-induced apoptosis. Moreover, A3D8 induces mitochondrial alterations (decrease in mitochondrial membrane potential DeltaPsi m and cytochrome c release), which are reduced by caspase-8 inhibitor, suggesting that caspase-8 is primarily involved in A3D8-induced apoptosis of NB4 cells. However, the apoptotic process is independent of TNF-family death receptor signalling. Interestingly, the general serine protease inhibitor 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF) decreases A3D8-induced apoptosis and when combined with general caspase inhibitor displays an additive effect resulting in complete prevention of apoptosis. These results suggest that both caspase-dependent and serine protease-dependent pathways contribute to A3D8-induced apoptosis. Finally, A3D8 induces apoptosis in all-trans-retinoic acid-resistant NB4-derived cells and in APL primary blasts, characterizing the A3D8 anti-CD44 mAb as a novel class of apoptosis-inducing agent in APL. 相似文献
9.
10.